Atorvastatin + Aspirin Tablet Supplier India, Atorable ASP 40/75 Franchise, Cardiovascular & Lipid-Lowering Tablet Distributor, Heart Health Tablet Manufacturer, Atorvastatin Aspirin Exporter, Cholesterol & Heart Protection Medicine Supplier, Cardiology Tablet Stockist India

Atorvastatin 40mg + Aspirin 75mg Tablet Franchise in Ahmedabad

Cardiovascular & Lipid-Lowering Tablet Supplier in Mumbai

Atorvastatin Aspirin Tablet Distributor in Delhi

Heart Health Tablet Franchise Opportunity in Bangalore
Atorvastatin + Aspirin Tablet Manufacturer & Exporter in Chandigarh

Home/Products /atorvastatin-40-mg-aspirin-75-mg-tablet

Atorable ASP 40-75 Tablet

Composition : Atorvastatin (40 mg) + Aspirin (75 mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Atorable ASP 40/75 Tablet contains Atorvastatin 40mg + Aspirin 75mg, a clinically proven combination for cardiovascular protection and lipid management. Atorvastatin reduces LDL cholesterol and triglycerides, while Aspirin provides antiplatelet action to prevent thrombotic events like heart attacks and strokes.

This combination is suitable for patients at high cardiovascular risk, including those with hyperlipidemia, coronary artery disease, or previous ischemic events. Its dual-action formulation improves compliance by minimizing pill burden and supporting overall heart health.

For distributors and resellers, Atorable ASP 40/75 Tablet is a high-demand cardiology product, widely prescribed in cardiology OPDs, hospitals, and preventive care centers. Its consistent need ensures year-round movement and repeat orders.

Read More

About the Product

Atorable ASP 40/75 Tablet contains Atorvastatin 40mg + Aspirin 75mg, a clinically proven combination for cardiovascular protection and lipid management. Atorvastatin reduces LDL cholesterol and triglycerides, while Aspirin provides antiplatelet action to prevent thrombotic events like heart attacks and strokes.

This combination is suitable for patients at high cardiovascular risk, including those with hyperlipidemia, coronary artery disease, or previous ischemic events. Its dual-action formulation improves compliance by minimizing pill burden and supporting overall heart health.

For distributors and resellers, Atorable ASP 40/75 Tablet is a high-demand cardiology product, widely prescribed in cardiology OPDs, hospitals, and preventive care centers. Its consistent need ensures year-round movement and repeat orders.

Some patients may experience headache, gastrointestinal discomfort, nausea, muscle pain, or mild bleeding tendencies. Rarely, severe muscle reactions (myopathy or rhabdomyolysis), liver enzyme elevation, or allergic reactions may occur.

Atorable ASP 40/75 Tablet is indicated for patients with hypercholesterolemia at risk of cardiovascular events and for the prevention of heart attack, stroke, and other thrombotic disorders, under medical supervision.

Use under medical supervision. Regular monitoring of liver function, cholesterol levels, and signs of bleeding is recommended. Avoid exceeding the prescribed dose and report any unusual muscle pain, weakness, or bruising to your physician.

Store Atorable ASP 40/75 Tablet in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation